Adenoid Cystic Carcinoma Organization International

Analysis

Adenoid Cystic Carcinoma Organization International is a registered charity in United States, based in San Francisco, CA. It received its IRS tax-exemption ruling in June 2003, 23 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Adenoid Cystic Carcinoma Organization International reported income of $64k and spending of $7,837, leaving 88% of income unspent that year. Across the 2 years on record, from December 2022 to December 2023, income grew from $36k to $64k (+80%), an average of +80% a year. The sharpest change came in the year to December 2023, when income rose by 80%. Over the whole period it spent 24% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Adenoid Cystic Carcinoma Organization International sits at the 20th percentile: it is larger than about 20% of them. Against every charity in United States with reported income it ranks in the 25th percentile, and in the 27th percentile within CA. Charities of a similar size with the same main cause include Watauga Development Corporation ($64k), Team Breast Friends ($64k) and Dent Disease Foundation ($64k).

On its Form 990-EZ for the period ending December 2023, revenue came from contributions and grants 88% of the total. At year end it held assets of $370k against liabilities of $147, net assets of $370k.